登陆/ 注册
×
Oryzon Genomics 电话:(617) 444-8786      邮箱:info@oryzon.com       官网: 成立时间:2000      地址:245 First Street, Suite 1800Cambridge, MA 02142
公司简介
ORYZON is a clinical stage biopharmaceutical company that discovers and develops innovative epigenetics-based therapeutics for patients with cancer and neurodegenerative disorders. We are able to identify biomarkers through our genomics and proteomics platforms and to translate them in advanced and personalized therapies.
主要成员

Roberto del Navío Alonso、Eric Lalanne、Emili Torrell、Enric Rello、Neus Virgili

产品/服务
OryzonEpigenetics。
Modulator Enzymes。
融资信息
融资轮次融资日期投资方融资额度
Series A2003-02未披露$1.1M
Undisclosed2006-01未披露undisclosed amount
Series B2008-03未披露$11M
Series C2015-10未披露$17M
Post Ipo Debt2016-09未披露$5.3M
关联公司